Lifeboat Foundation

An international team of researchers led by University of Wisconsin-Madison scientists has developed an easily implantable weight-loss device. In lab experiments, the device helped rats shed 38% of their body weight.

The most deadly aspect of breast cancer is metastasis, cancer cells spreading throughout the body. Researchers at the University and the University Hospital of Basel have now discovered a substance that suppresses the formation of metastases. In the journal Cell, the team of molecular biologists, co…

Celebrate Bedford Day, a celebration of the first human to be placed into cryonic suspension.

Dr. James Bedford is the oldest person currently in Cryostasis.

Continue reading “Bedford Day Celebration with Ben Best” »

Researchers have developed new bioinspired material that interacts with surrounding tissues to promote healing.

‘Right to Try’ law allows patients and drugmakers to circumvent the FDA’s rules on access to experimental drugs.

A University of Wisconsin-Madison researcher and his collaborators at the University of California, San Francisco have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.

Through treating everything from strokes to car accident traumas, neurosurgeon Jocelyne Bloch knows the brain’s inability to repair itself all too well. But now, she suggests, she and her colleagues may have found the key to neural repair: Doublecortin-positive cells. Similar to stem cells, they are extremely adaptable and, when extracted from a brain, cultured and then re-injected in a lesioned area of the same brain, they can help repair and rebuild it. “With a little help,” Bloch says, “the brain may be able to help itself.”

David is a paraplegic — but now he can walk again.

A total knee replacement is usually the result of the cartilage within the joint wearing out due to arthritis. Such surgeries are difficult to perform, require a good deal of rehabilitation, and too often result in sub-optimal outcomes. An implantable shock absorber has now been implanted for the first time in the United States to test whether it can delay the need for total knee replacements, and maybe even avoid such procedures completely in many patients.

The Calypso Knee System was developed by Moximed, a company based in Fremont, California, and surgeons at The Ohio State University Wexner Medical Center are the first to try it out in the U.S. The device attaches to the sides of the femur and tibia bones, away from the joint itself and therefore doesn’t alter the anatomy of the fragile joint.

Continue reading “Implantable Knee Shock Absorber Embedded in First Patient in U.S.” »